Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
filingDate |
1998-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1999-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1229204194dce1238e61f431002158ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06e6c091cca89a38dc6b23e80dcd886c |
publicationDate |
1999-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5965155-A |
titleOfInvention |
Transdermal therapeutic system with pentylene tetrazol as active substance |
abstract |
The invention relates to a pharmaceutic product as well as to a process for its production for a transdermal application in the prophylaxis and treatment of vasodilations, said pharmaceutic product comprising at least one skin-compatible auxiliary agent and portions of an active substance, characterized in that said pharmaceutic product contains as active substance pentetrazole. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8784880-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9289397-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011020450-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015176800-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2946776-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004208917-A1 |
priorityDate |
1992-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |